RCE
Click for more information
1.02% 48.5¢ recce pharmaceuticals ltd

Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    09/12/22
    10:26
    Post #: 65235973
    Likes Created with Sketch. 13  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
48.5¢ 		Change
-0.005(1.02%) 		Mkt cap ! $98.93M
Open High Low Value Volume
49.5¢ 49.5¢ 48.0¢ $72.39K 149.2K

Buyers (Bids)

No. Vol. Price($)
1 80000 48.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.5¢ 100032 2
View Market Depth
Last trade - 13.10pm 03/07/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.